HUMA
Humacyte Sets Stage for Global Expansion with Strong Q4 2025 Results
Humacyte, a leader in bioengineered vessel technologies, has announced strong fourth quarter and full year 2025 results, setting the stage for global expansion of its flagship product Symvess. In a conference call on March 27, 2026, Humacyte's President and Chief Executive Officer Dr. Laura Niklason highlighted the company&